RecruitingNot ApplicableNCT04639388

Understanding of Psychotic Disorders in Children With 22q11.2DS

Characterize the Behavioral Prodromes of Psychotic Disorders in Children With 22q11.2DS Aged From 4 to 13 Years Old


Sponsor

Hôpital le Vinatier

Enrollment

80 participants

Start Date

Nov 13, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome


Eligibility

Min Age: 4 YearsMax Age: 13 Years

Inclusion Criteria3

  • Diagnosis of 22q11.2 deletion syndrome or no developmental disease
  • Aged from 4 to 13 years old
  • French language

Exclusion Criteria2

  • Diagnosis of intellectual deficiency according to DSM 5 criteria
  • Drug prescribed for somatic condition that could influence cerebral functioning

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALneuropsychological testing, questionnaires and experimental tasks

Neuropsychological testing (the Sky Search subtest from the Test of Everyday Attention for Children (TEA-Ch); the Overlapping lines task of Rey; auditory attention of NEPSY II battery); questionnaires completed by the children's legal representatives to assess behavior; experimental tasks evaluating gaze direction and facial expression recognition


Locations(1)

Hopital Vinatier

Lyon, Auvergne-Rhône-Alpes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04639388


Related Trials